GGrantIndex
Sort

40,608 grants matching prostate cancer

Drug Mechanism of Action-based targeting of tumor subpopulations

$479,435
Andrea Califano · Columbia University Health Sciences · U54 · FY2023 · CA

Molecular Epidemiology of Prostate Cancer in Tobagonians

$479,428
Clareann H. Bunker · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · CA

Utilizing islet autoantibody signatures for precision medicine in type 2 diabetes

$479,389
Nisa M Maruthur · Johns Hopkins University · R01 · FY2021 · DK

B7-H1/PD-1 modulation in cancer therapy

$479,334
Drew M. Pardoll · Johns Hopkins University · R01 · FY2011 · CA

QuBBD: Collaborative Research: Quantifying Morphologic Phenotypes in Prostate Cancer - Developing Topological Descriptors for Machine Learning Algorithms

$479,293
Carola Wenk · Tulane University · · FY2017 · MPS

Longevity and Medical Treatment in Old Age

$479,256
Sharon R Kaufman · University Of California, San Francisco · R01 · FY2010 · AG

GENETIC EPIDEMIOLOGY OF PROSTATE CANCER AGGRESSIVENESS

$479,118
Case Western Reserve University · R01 · FY2001 · CA

Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases

$479,104
David R Rowley · Baylor College Of Medicine · R01 · FY2022 · CA

THE STEM CELL MARKER SALL4 AND CIRCULATING TUMOR CELLS AS BIOMARKERS FOR PROSTATE CANCER PROGNOSES AND THERAPEUTICS

$479,000
Nevada Cancer Institute · · FY2008 · Department of Energy

SUBMICROGRAM EPIGENETIC ANALYSIS FOR PROSTATE CANCER DETECTION WITH THE ARIA SYSTEM.

$478,930
Beckman Research Institute Of The City Of Hope · · FY2008 · Department of the Army

MR Guided Focused Ultrasound Surgery for Prostate Cancer

$478,840
Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2008 · CA

Oncogenic Met Signaling in Urologic Malignancies

$478,765
Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Immunopathogenesis Of Chlamydia trachomatis Infection

$478,744
Thomas Quinn · Niaid Extramural Activities · Z01 · FY2007 · AI

USP22 Function in Advanced Prostate Cancer

$478,693
Karen E Knudsen · Thomas Jefferson University · R01 · FY2019 · CA

Deciphering the molecular mechanisms of histone code recognition by ATAD2/B

$478,681
Karen Champagne Glass · Albany College Of Pharmacy · R01 · FY2019 · GM

NCCU-BBRI/UNC-LINEBERGER PARTNERSHIP IN CANCER RESEARCH

$478,674
North Carolina Central University · U56 · FY2004 · CA

Role of GATA2 signaling network in Lethal Prostate Cancer

$478,637
Josep Maria Domingo-Domenech · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA

Appraisal Delay and Disparities in Timely Cancer Diagnosis

$478,554
Laura A Siminoff · Virginia Commonwealth University · R01 · FY2010 · CA

A Hard and Clear, Estrogen-Free Replacement for Bisphenol-A Based Polycarbonates

$478,484
Yantian Wang · Plastipure, Inc. · R44 · FY2014 · ES

A Hard and Clear, Estrogen-Free Replacement for Bisphenol-A Based Polycarbonates

$478,484
George Bittner · Plastipure, Inc. · R44 · FY2013 · ES

Outcomes of Triaged Family Care in Advanced Cancer

$478,377
Laurel L. Northouse · University Of Michigan At Ann Arbor · R01 · FY2008 · CA

Comprehensive analyses of HOXB13-regulated transcriptional programs critical for prostate cancer progression

$478,370
Jindan Yu · Northwestern University At Chicago · R01 · FY2022 · CA

Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies

$478,329
Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies

$478,329
Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Case Control Study of Pancreas Cancer in Shanghai, China

$478,305
Harvey A Risch · Yale University · R01 · FY2010 · CA